Related Experiment Video
Updated: Aug 3, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
PAs as principal investigators of FDA-regulated clinical trials
Colleen Elizabeth Gosa Nalepinski1
1Colleen Elizabeth Gosa Nalepinski is decentralized clinical trials director in research nursing and phlebotomy solutions at IQVIA in Durham, N.C.; a clinical assistant professor at Marquette University in Milwaukee, Wisc.; and a principal investigator at Spaulding Clinical Research in West Bend, Wisc. The author has disclosed no potential conflicts of interest, financial or otherwise.
Abstract:
A misconception exists that only physicians can be principal investigators for FDA-regulated human clinical trials such as interventional studies. This article reviews existing guidelines and dispels the notion that physician associates/assistants (PAs) cannot be principal investigators for clinical trials. Additionally, this article describes an implementation plan to correct the misconception and establish a reference for future PAs seeking the role of principal investigator in clinical trials.
Insights
Physician Associates/Assistants (PAs) can serve as principal investigators in FDA-regulated clinical trials, challenging a common misconception. This article clarifies guidelines and provides a plan to support PAs in this crucial research role.
Area of Science:
- Clinical Research
- Regulatory Affairs
- Medical Practice
Background:
- A prevalent misconception suggests only physicians can lead FDA-regulated clinical trials.
- This limits the potential pool of qualified principal investigators.
Approach:
- This article systematically reviews current FDA guidelines and relevant literature.
- It analyzes the regulatory framework governing PI eligibility for human clinical trials.
- An implementation strategy is proposed to address and rectify the existing misconception.
Key Points:
- Physician Associates/Assistants (PAs) are legally and ethically qualified to serve as Principal Investigators (PIs) for FDA-regulated clinical trials.
- Existing guidelines do not restrict PI roles exclusively to physicians.
- Clarifying these guidelines empowers PAs to pursue and excel in PI positions.
Conclusions:
- Physician Associates/Assistants are qualified to be principal investigators in clinical trials.
- Addressing this misconception will broaden access to clinical research leadership.
- Implementation of a support plan is recommended for PAs pursuing PI roles.
More Related Videos
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Preclinical Development: Overview
Drug Regulation
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...